RxDoctor Payments Data

Corey Steinberg, MD

Family Medicine · Tampa, FLNPI 1497174734

Payments from drug & device makers

$615in general payments, 2019–2025

Across 28 payments — averaging $21.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$104
  • Novo Nordisk$78
  • GSK$45
  • Boston Scientific$45
  • Exact Sciences$42
  • Inspire Medical Systems, Inc.$40
  • plus $260 from 9 others

What the payments were for

  • Food & beverage$60198%
  • Education$142%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$615 in reported general payments places this provider in the 55th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$222,371
Medicare patients
376
Services billed
4,240

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide69$99,529
EliquisApixaban86$84,797
JardianceEmpagliflozin58$74,000
OzempicSemaglutide58$66,881
XareltoRivaroxaban50$53,106
RybelsusSemaglutide17$27,660
JanuviaSitagliptin Phosphate32$23,622
ProliaDenosumab13$22,622
NexletolBempedoic Acid25$22,204
Repatha SureclickEvolocumab23$12,357
Rosuvastatin Calcium453$5,467
SymbicortBudesonide/Formoterol Fumarate22$4,903
Tresiba Flextouch U-100Insulin Degludec11$4,883
Atorvastatin Calcium367$3,775
SynthroidLevothyroxine Sodium35$3,739

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$37$99,52969 claims
Novo NordiskOzempic, Rybelsus$78$94,54275 claims
PfizerEliquis$32$84,79786 claims
MerckJanuvia$23$23,62232 claims
AmgenProlia$104$22,62213 claims
AstraZenecaSymbicort$21$4,90322 claims
AbbVieSynthroid, Armour Thyroid$27$4,58748 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →